Heartflow, Inc.
HTFLHealthcareNASDAQHealth Information Services
Scan Results
Daily timeframeOperating under the Health Information Services umbrella, Heartflow, Inc. is a healthcare company. HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. The company carries a $4.93B market cap, placing it firmly in the mid-cap category. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
Market Cap
$4.93B
Beta
—
P/E (TTM)
—
P/E (Fwd)
-209.39
EPS (TTM)
$-0.24
EPS (Fwd)
$-0.27
ROE
-154.2%
ROA
-18.1%
Cash
$162.6M
Total Debt
$27.1M
Free CF
-$33.6M
52W Change
47.9%
Annual Financials
Cash vs Debt
Where HTFL stands vs its 150-day and 200-day moving averages
As of the September 10, 2026 close, HTFL finished 55.46% above its 150-day moving average ($30.02) and 54.90% above its 200-day moving average ($30.13). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HTFL overbought or oversold?
At the September 10, 2026 close, HTFL's RSI(14) was 54.2, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Heartflow, Inc. holds $162.6M in cash against $27.1M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. The company is burning cash, with free cash flow at -$33.6M. This typically occurs when a company is investing aggressively in growth, but sustained cash burn can strain the balance sheet. ROE of -154.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from $87.2M (2023) to $176.0M (2025), reflecting a 102% increase over the period.
With cash comfortably exceeding debt, HTFL has financial flexibility that may help navigate uncertain periods. Negative free cash flow means the company is currently spending more than it generates, which may require future fundraising or debt if the trend continues. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Heartflow, Inc.'s trajectory.